Most reported malaria cases in EU were travel related. Five cases were reported as locally acquired: two in France and three in Spain. The latest data on reported cases in EU is available in the 2016 Annual epidemiological report.
Immunisation is the only effective method of prevention. Mumps vaccine is given in the form of the combined trivalent measles-mumps-rubella (MMR) vaccine in all European countries with a first dose at or before 18 months of age. The timing of the second dose varies across countries.
Malaria is caused by Plasmodium parasites. During the 20th century, malaria was eradicated from many temperate areas, including the whole of the EU, and is now limited to tropical countries. Due to the large number of imported cases in Europe, malaria is mainly a travel medicine issue.
Annual Epidemiological Report on the Hantavirus infection, 2014. ECDC’s annual surveillance reports provide a wealth of epidemiological data to support decision-making at the national level. They are mainly intended for public health professionals and policymakers involved in disease prevention and control programmes.
In 2014, 11 069 cases of mumps were reported to TESSy. The notification rate was 2.5 cases per 100 000 population, less than half the notification rate observed in 2012 and 2013.
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 21-27 August 2016 and includes updates on Zika virus, yellow fever, West Nile fever and malaria in Greece.